Hogge J, Krasner D, Nguyen H, Harkless L B, Armstrong D G
Department of Orthopaedics, University of Texas Health Science Center, San Antonio 78284-7776, USA.
J Am Podiatr Med Assoc. 2000 Feb;90(2):57-65. doi: 10.7547/87507315-90-2-57.
This article discusses the advantages and disadvantages of primary wound healing as compared with primary amputation in individuals with chronic diabetic foot wounds. The authors review the potential benefits of vascular surgical procedures and advanced dressings, including two of the most promising modalities in modern wound care: growth factors and bioengineered skin. In this era of cost-conscious health-care administration, it is incumbent on the practitioner to consider not only the basic science of wound care, but also the economic aspect of treatment rendered. These various interventions, dressings, growth factor delivery systems, and new modalities could significantly reduce healing time, thereby reducing the risk of infection, hospitalization, and amputation while improving quality of life. If so, they may be truly cost-effective.
本文讨论了慢性糖尿病足伤口患者一期伤口愈合与一期截肢相比的优缺点。作者回顾了血管外科手术和先进敷料的潜在益处,包括现代伤口护理中最有前景的两种模式:生长因子和生物工程皮肤。在这个注重医疗成本管理的时代,从业者不仅要考虑伤口护理的基础科学,还要考虑所提供治疗的经济方面。这些各种干预措施、敷料、生长因子递送系统和新模式可以显著缩短愈合时间,从而降低感染、住院和截肢的风险,同时提高生活质量。如果是这样,它们可能真的具有成本效益。